Page last updated: 2024-11-04

oxoamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oxoamide: cotinine metabolite; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID436
CHEMBL ID3544600
CHEBI ID166504
SCHEMBL ID1954553
MeSH IDM0107413

Synonyms (23)

Synonym
713-05-3
n-methyl-4-oxo-4-pyridin-3-ylbutanamide
CHEBI:166504
4-(3-pyridyl)-4-oxo-n-methylbutyramide
4-oxo-4-(3-pyridyl)-n-methylbutanamide
gamma-(3-pyridyl)-gamma-oxo-n-methylbutyramide
oxoamide
n-methyl-|a-oxo-3-pyridinebutanamide
n-methyl-gamma-oxo-3-pyridinebutanamide
AKOS006293668
3-pyridinebutanamide, n-methyl-gamma-oxo-
unii-ol86r2uld8
ol86r2uld8 ,
FT-0672083
3-pyridinebutanamide,n-methyl-g-oxo-
SCHEMBL1954553
CHEMBL3544600
n-methyl-4-oxo-4-(pyridin-3-yl)butanamide
n-methyl-g-oxo-3-pyridinebutanamide
ba-2702
.gamma.-(3-pyridyl)-.gamma.-oxo-n-methylbutyramide
n-methyl- gamma -oxo-3-pyridinebutanamide
DTXSID80862385
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
nicotine degradation III4326

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's0 (0.00)18.2507
2000's5 (31.25)29.6817
2010's10 (62.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.39 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]